Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 92
Filter
Add more filters










Publication year range
1.
J Biol Chem ; 275(13): 9550-6, 2000 Mar 31.
Article in English | MEDLINE | ID: mdl-10734104

ABSTRACT

Chemokines mediate their diverse activities through G protein-coupled receptors. The human homolog of the bovine orphan receptor PPR1 shares significant similarity to chemokine receptors. Transfection of this receptor into murine L1.2 cells resulted in responsiveness to monocyte chemoattractant protein (MCP)-4, MCP-2, and MCP-1 in chemotaxis assays. Binding studies with radiolabeled MCP-4 demonstrated a single high affinity binding site with an IC(50) of 0.14 nM. As shown by competition binding, other members of the MCP family also recognized this receptor. MCP-2 was the next most potent ligand, with an IC(50) of 0.45 nM. Surprisingly, eotaxin (IC(50) = 6.7 nM) and MCP-3 (IC(50) = 4.1 nM) bind with greater affinity than MCP-1 (IC(50) = 10.7 nM) but only act as agonists in chemotaxis assays at 100-fold higher concentrations. Because of high affinity binding and functional chemotactic responses, we have termed this receptor CCR11. The gene for CCR11 was localized to human chromosome 3q22, which is distinct from most CC chemokine receptor genes at 3p21. Northern blot hybridization was used to identify CCR11 expression in heart, small intestine, and lung. Thus CCR11 shares functional similarity to CCR2 because it recognizes members of the MCP family, but CCR11 has a distinct expression pattern.


Subject(s)
Monocyte Chemoattractant Proteins/metabolism , Receptors, Chemokine/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cattle , Chromosome Mapping , Chromosomes, Human, Pair 3 , DNA, Complementary , Humans , Mice , Molecular Sequence Data , Protein Binding , Receptors, CCR , Receptors, Chemokine/chemistry , Receptors, Chemokine/genetics , Sequence Homology, Amino Acid
2.
Blood ; 95(4): 1151-7, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10666184

ABSTRACT

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes 3 genes that are homologous to cellular chemokines. vMIP-III, the product of open reading frame K4.1, is the most distantly related to human chemokines and has yet to be characterized. We have examined the interaction of vMIP-III with chemokine receptors, its expression in KS lesions, and its in ovo angiogenic properties. We show expression of vMIP-III in KS lesions and demonstrate the stimulation of angiogenesis by this chemokine, like vMIP-I and vMIP-II, in the chick chorioallantoic membrane assay. vMIP-III does not block human immunodeficiency virus entry through the coreceptors CCR3, CCR5, or CXCR4. However, vMIP-III is an agonist for the cellular chemokine receptor CCR4. CCR4 is expressed by TH2-type T cells. Consistent with this, vMIP-III preferentially chemoattracts this cell type. Because of these biologic properties and because it is expressed in KS lesions, vMIP-III may play an important role in the pathobiology of KS. (Blood. 2000;95:1151-1157)


Subject(s)
Chemokines, CC/genetics , Chemokines, CC/pharmacology , Chemokines, CC/physiology , Herpesvirus 8, Human/genetics , Neovascularization, Physiologic/physiology , Receptors, Chemokine/agonists , Th2 Cells/physiology , Allantois/blood supply , Animals , CHO Cells , Cell Line , Chemokines, CC/immunology , Chemotaxis/drug effects , Chemotaxis/physiology , Chick Embryo , Chorion/blood supply , Cricetinae , HIV/drug effects , HIV/physiology , Herpesvirus 8, Human/immunology , Humans , Neovascularization, Physiologic/drug effects , Open Reading Frames , Receptors, CCR4 , Recombinant Proteins/immunology , Recombinant Proteins/pharmacology , Sarcoma, Kaposi/immunology , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/virology , Th1 Cells/drug effects , Th1 Cells/physiology , Th2 Cells/drug effects , Transfection , Viral Proteins , Virus Replication/drug effects
3.
J Biol Chem ; 275(1): 514-20, 2000 Jan 07.
Article in English | MEDLINE | ID: mdl-10617646

ABSTRACT

Mammalian chitinase, a chitinolytic enzyme expressed by macrophages, has been detected in atherosclerotic plaques and is elevated in blood and tissues of guinea pigs infected with Aspergillus. Its normal physiological function is unknown. To understand how the enzyme interacts with its substrate, we have characterized the chitin-binding domain. The C-terminal 49 amino acids make up the minimal sequence required for chitin binding activity. The absence of this domain does not affect the ability of the enzyme to hydrolyze the soluble substrate, triacetylchitotriose, but abolishes hydrolysis of insoluble chitin. Within the minimal chitin-binding domain are six cysteines; mutation of any one of these to serine results in complete loss of chitin binding activity. Analysis of purified recombinant chitin-binding domain revealed the presence of three disulfide linkages. The recombinant domain binds specifically to chitin but does not bind chitosan, cellulose, xylan, beta-1, 3-glucan, beta-1,3-1,4-glucan, or mannan. Fluorescently tagged chitin-binding domain was used to demonstrate chitin-specific binding to Saccharomyces cerevisiae, Candida albicans, Mucor rouxii, and Neurospora crassa. These experiments define structural features of the minimal domain of human chitinase required for both specifically binding to and hydrolyzing insoluble chitin and demonstrate relevant binding within the context of the fungal cell wall.


Subject(s)
Chitin/metabolism , Chitinases/metabolism , Amino Acid Sequence , Binding Sites , Candida albicans/chemistry , Candida albicans/ultrastructure , Cell Wall/chemistry , Cell Wall/ultrastructure , Chitinases/genetics , Cysteine/metabolism , Fungi , Humans , Hydrolysis , Molecular Sequence Data , Mucor/chemistry , Mucor/ultrastructure , Point Mutation , Protein Binding , Recombinant Proteins/metabolism , Substrate Specificity , Trisaccharides/chemistry , Trisaccharides/metabolism
4.
Immunol Rev ; 177: 112-26, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11138769

ABSTRACT

Human and simian immunodeficiency viruses (HIV and SIV) require a seven transmembrane chemokine (7TM) receptor in addition to CD4 for efficient entry into cells. CCR5 and CXCR4 act as major co-receptors for non-syncytium-inducing and syncytium-inducing strains respectively. We have examined the co-receptor requirement for HIV-1 infection of cells of macrophage lineage. Both CCR5 and CXCR4 can operate as functional co-receptors for infection in these cell types. Other co-receptors utilised by multi-co-receptor-using strains of HIV-1, including CCR3 and STRL33, were not used for macrophage infection. HIV-2 and SIV strains, however, can replicate in both peripheral blood mononuclear cells (PBMCs) and other primary cell types such as fibroblasts independently of CCR5 or CXCR4. HIV co-receptors, particularly CCR5, will be major targets for new therapeutics in this decade. We have therefore investigated different chemokines and derivatives that bind co-receptors for their capacity to inhibit HIV infection. These included derivatives of a CCR5 ligand, RANTES, with modified N-termini as well as Kaposi's sarcoma-associated herpesvirus-encoded chemokines that bind a wide range of co-receptors, including CCR5, CXCR4, CCR3 and CCR8, as well as the orphan 7TM receptors GPR1 and STRL33. One compound, aminooxypentane or AOP-RANTES, was a particularly potent inhibitor of HIV infection on PBMCs, macrophages and CCR5+ cell lines and demonstrated the great promise of therapeutic strategies aimed at CCR5.


Subject(s)
HIV Infections/immunology , HIV-1/immunology , HIV-2/immunology , Receptors, Chemokine/immunology , Receptors, HIV/immunology , Chemokines/immunology , Humans , Ligands
5.
Eur J Immunol ; 30(1): 204-10, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10602042

ABSTRACT

Macrophage-derived chemokine (MDC), a potent chemoattractant for chronically activated Th2 lymphocytes, is constitutively expressed by dendritic cells, B cells, macrophages, and thymic medullary epithelial cells, whereas monocytes, NK cells, and T lymphocytes produce MDC only upon appropriate stimulation. In this study, we show in vitro MDC production also by activated T cells, which preferentially associate with the production of Th2 cytokines, IL-4, IL-5, and IL-6, and inversely correlate with the production of the Th1 cytokine, IFN-gamma. Moreover, high levels of MDC were detected in the sera of the great majority of subjects suffering from mycosis fungoides/Sézary syndrome or atopic dermatitis, which are considered as disorders characterized by the predominant expansion and activation of Th2 cells, respectively. By contrast, serum MDC levels in subjects with multiple sclerosis or Crohn's disease, which are characterized by a Th1 predominance, did not differ significantly from those of healthy controls. Finally, MDC expression was detected in the skin biopsy specimens of subjects with atopic dermatitis, where it was expressed by both dendritic cells and T lymphocytes. Taken together, these findings suggest that MDC production by activated T cells may occur both in vitro and in vivo, particularly in association with Th2 cytokines, thus providing an important amplification circuit for Th2-mediated responses.


Subject(s)
Chemokines, CC/biosynthesis , Cytokines/biosynthesis , Lymphocyte Activation , Macrophages/physiology , T-Lymphocytes/metabolism , Th2 Cells/physiology , Biopsy , Cell Line , Dermatitis, Atopic/immunology , Humans , Skin/chemistry
6.
Blood ; 94(6): 1890-8, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10477717

ABSTRACT

Macrophage-derived chemokine (MDC) is a recently identified CC chemokine that is a potent chemoattractant for dendritic cells, natural killer (NK) cells, and the Th2 subset of peripheral blood T cells. In normal tissues, MDC mRNA is expressed principally in the thymus. Immunohistochemical analysis performed on 5 human postnatal thymuses showed high MDC immunoreactivity, which was selectively localized to epithelial cells within the medulla. To examine the effects of MDC on immature T cells, we have identified cDNA clones for mouse and rat MDC. Expression of MDC in murine tissues is also highly restricted, with significant levels of mRNA found only in the thymus. Thymocytes express high-affinity binding sites for MDC (kd = 0.7 nmol/L), and, in vitro, MDC is a chemoattractant for these cells. MDC-responsive murine thymocytes express mRNA for CCR4, a recently identified receptor for MDC. Phenotypic analysis of MDC-responsive cells shows that they are enriched for a subset of double-positive cells that express high levels of CD3 and CD4 and that have reduced levels of CD8. This subset of MDC-responsive cells is consistent with the observed expression of MDC within the medulla, because more mature cells are found there. MDC may therefore play a role in the migration of T-cell subsets during development within the thymus.


Subject(s)
CD4-Positive T-Lymphocytes/physiology , CD8-Positive T-Lymphocytes/physiology , Chemokines, CC/physiology , Chemotaxis, Leukocyte , Epithelial Cells/immunology , T-Lymphocyte Subsets/physiology , Thymus Gland/immunology , Amino Acid Sequence , Animals , CD3 Complex/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Chemokine CCL22 , Chemokines, CC/analysis , Chemokines, CC/chemistry , Child , Child, Preschool , Epithelial Cells/cytology , Female , Humans , Infant , Infant, Newborn , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Phylogeny , Rats , Sequence Alignment , Sequence Homology, Amino Acid , T-Lymphocyte Subsets/immunology , Thymus Gland/cytology
7.
AIDS Res Hum Retroviruses ; 15(11): 989-1000, 1999 Jul 20.
Article in English | MEDLINE | ID: mdl-10445811

ABSTRACT

The capacity of a panel of HIV-1 isolates to infect primary mixed fetal brain cell cultures was estimated and their sensitivity to inhibition by a range of coreceptor ligands assessed. Our results show that (1) HIV-1 strains that predominantly use CCR5 or only CXCR4 are able to infect microglia in primary brain cell cultures, and (2) ligands to these two coreceptors can inhibit brain cell infection. CCR5 ligands (including AOP-RANTES, a potent inhibitor of CCR5-dependent infection), however, blocked infection only weakly, raising the possibility that alternative unidentified coreceptors are also used. Interestingly, vMIP-II, a chemokine encoded by the Kaposi sarcoma-associated herpes virus (KSHV), reduced brain cell infection by all HIV-1 strains tested, including both R5 and X4 viruses. Our results therefore indicate that novel drugs targeted to the major HIV-1 coreceptors will influence HIV replication in the brain, if they cross the blood-brain barrier.


Subject(s)
Brain/enzymology , Brain/virology , HIV-1/pathogenicity , Receptors, CCR5/metabolism , Receptors, CXCR4/metabolism , Anti-HIV Agents/pharmacology , Brain/drug effects , Cells, Cultured , Chemokine CCL5/analogs & derivatives , Chemokine CCL5/pharmacology , Chemokines/pharmacology , HIV-1/metabolism , Humans , Ligands , Microglia/virology
8.
J Biol Chem ; 274(11): 7018-24, 1999 Mar 12.
Article in English | MEDLINE | ID: mdl-10066756

ABSTRACT

The platelet-activating factor acetylhydrolases are enzymes that were initially characterized by their ability to hydrolyze platelet-activating factor (PAF). In human plasma, PAF acetylhydrolase (EC 3.1.1.47) circulates in a complex with low density lipoproteins (LDL) and high density lipoproteins (HDL). This association defines the physical state of PAF acetylhydrolase, confers a long half-life, and is a major determinant of its catalytic efficiency in vivo. The lipoprotein-associated enzyme accounts for all of the PAF hydrolysis in plasma but only two-thirds of the protein mass. To characterize the enzyme-lipoprotein interaction, we employed site-directed mutagenesis techniques. Two domains within the primary sequence of human PAF acetylhydrolase, tyrosine 205 and residues 115 and 116, were important for its binding to LDL. Mutation or deletion of those sequences prevented the association of the enzyme with lipoproteins. When residues 115 and 116 from human PAF acetylhydrolase were introduced into mouse PAF acetylhydrolase (which normally does not associate with LDL), the mutant mouse PAF acetylhydrolase associated with lipoproteins. To analyze the role of apolipoprotein (apo) B100 in the formation of the PAF acetylhydrolase-LDL complex, we tested the ability of PAF acetylhydrolase to bind to lipoproteins containing truncated forms of apoB. These studies indicated that the carboxyl terminus of apoB plays a key role in the association of PAF acetylhydrolase with LDL. These data on the molecular basis of the PAF acetylhydrolase-LDL association provide a new level of understanding regarding the pathway for the catabolism of PAF in human blood.


Subject(s)
Lipoproteins, LDL/metabolism , Phospholipases A/metabolism , 1-Alkyl-2-acetylglycerophosphocholine Esterase , Animals , Humans , Mice , Mice, Transgenic , Mutagenesis, Site-Directed , Phospholipases A/genetics , Protein Binding , Recombinant Proteins/metabolism , Tyrosine/metabolism
9.
J Allergy Clin Immunol ; 103(3 Pt 1): 527-32, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10069890

ABSTRACT

BACKGROUND: Chemokines are believed to contribute to selective cell recruitment. Macrophage-derived chemokine (MDC) is a CC chemokine that causes chemotaxis of dendritic cells, monocytes, and activated natural killer cells. MDC binds to CC chemokine receptor 4 (CCR4) but not to CCR1, CCR2, CCR3, CCR5, CCR6, or CCR7. OBJECTIVE: Our aim was to determine the in vitro activity of MDC on human eosinophils by using chemotaxis and calcium flux assays. METHODS: Eosinophils were purified from peripheral blood of allergic donors, and chemotactic activity of MDC and other CC chemokines was compared in microchemotaxis chamber assays. The role of CCR3 in these assays was determined by using a CCR3-blocking antibody. Measurements of cytosolic Ca++ mobilization were performed by using fura-2AM labeling, with eosinophils and cell lines transfected with CCR3 or CCR4. Eosinophil expression of CCR3 and CCR4 mRNA was determined by using RT-PCR. RESULTS: MDC (0.1 to 100 nmol/L) caused dose-dependent chemotaxis of purified human eosinophils (maximum approximately 3-fold control). Compared with other CC chemokines, the potency and efficacy for eosinophil chemotaxis were similar for MDC and eotaxin but were less than that observed for RANTES, monocyte chemoattractant protein (MCP)-4, and eotaxin-2. Although MDC can act by means of CCR4, RT-PCR analysis failed to reveal CCR4 mRNA in eosinophils. Effects of MDC on eosinophils was also independent of CCR3, as a blocking mAb to CCR3 failed to inhibit MDC-induced chemotaxis. Furthermore, CCR3-transfected human embryonic kidney cells labeled with Fura-2AM exhibited a rapid rise in intracellular free calcium after stimulation with eotaxin, eotaxin-2, or MCP-4, but not with MDC. Eosinophils cultured for 72 hours in 10 ng/mL IL-5 also demonstrated increased intracellular free calcium after stimulation with eotaxin-2 or MCP-4, but not with up to 100 nmol/L MDC. CONCLUSION: MDC is a CCR3- and CCR4-independent activator of eosinophil chemotaxis, but it does not appear to elicit measurable cytosolic calcium elevations during these responses. MDC appears to act by means of another receptor in addition to CCR4 and may therefore contribute to eosinophil accumulation without working through CCR1 to CCR7.


Subject(s)
Chemokines, CC/pharmacology , Chemotaxis, Leukocyte/drug effects , Calcium Signaling/drug effects , Cells, Cultured , Chemokine CCL22 , Chemokine CCL24 , Chemokine CCL5/pharmacology , Dose-Response Relationship, Drug , Eosinophils , Humans , Hypersensitivity/blood , Kidney , Monocyte Chemoattractant Proteins/pharmacology , Polymerase Chain Reaction , RNA, Messenger/blood , Receptors, CCR3 , Receptors, CCR4 , Receptors, Chemokine/genetics , Receptors, Chemokine/physiology , Recombinant Fusion Proteins/physiology , Transfection
10.
Int Immunol ; 11(1): 81-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10050676

ABSTRACT

Helper T cells are classified into Th1 and Th2 subsets based on their profiles of cytokine production. Th1 cells are involved in cell-mediated immunity, whereas Th2 cells induce humoral responses. Selective recruitment of these two subsets depends on specific adhesion molecules and specific chemoattractants. Here, we demonstrate that the T cell-directed CC chemokine thymus and activation-regulated chemokine (TARC) was abundantly produced by monocytes treated with granulocyte macrophage colony stimulating factor (GM-CSF) or IL-3, especially in the presence of IL-4 and by dendritic cells derived from monocytes cultured with GM-CSF + IL-4. The receptor for TARC and another macrophage/dendritic cell-derived CC chemokine macrophage-derived chemokine (MDC) is CCR4, a G protein-coupled receptor. CCR4 was found to be expressed on approximately 20% of adult peripheral blood effector/memory CD4+ T cells. T cells attracted by TARC and MDC generated cell lines predominantly producing Th2-type cytokines, IL-4 and IL-5. Fractionated CCR4+ cells but not CCR4- cells also selectively gave rise to Th2-type cell lines. When naive CD4+ T cells from adult peripheral blood were polarized in vitro, Th2-type cells selectively expressed CCR4 and vigorously migrated toward TARC and MDC. Taken together, CCR4 is selectively expressed on Th2-type T cells and antigen-presenting cells may recruit Th2 cells expressing CCR4 by producing TARC and MDC in Th2-dominant conditions.


Subject(s)
Antigen-Presenting Cells/immunology , Chemokines/immunology , Chemotaxis, Leukocyte , Receptors, Chemokine/immunology , Th2 Cells/immunology , Thymus Gland/immunology , Antigens, Differentiation, T-Lymphocyte , CD4-Positive T-Lymphocytes , Chemokine CCL17 , Chemokine CCL22 , Chemokines, CC/immunology , Dendritic Cells/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Immunologic Memory , Interleukin-3/pharmacology , Interleukin-4/pharmacology , Leukocyte Common Antigens , Macrophages/immunology , Monocytes/immunology , Receptors, CCR4 , T-Lymphocyte Subsets
11.
Adv Exp Med Biol ; 469: 351-6, 1999.
Article in English | MEDLINE | ID: mdl-10667352

ABSTRACT

In this report we describe a pair of human LPAAT isozymes. These isozymes are encoded by distinct genes located on different chromosomes, but share sequence homology, substrate specificity, and intracellular location. The biological value of maintaining the two closely related LPAAT genes in the human genome is not clear. We find that both isozymes are widely expressed, although expression levels do diverge significantly in tissues such as the liver, placenta, testes, and pancreas. We also find that, at least in the artificial system of over-expression in COS7 cells, both isozymes localize to the ER membrane. Thus, distinct tissue-specific or subcellular compartment-specific roles for the two isozymes are not supported by the current experimental evidence. It does remain possible that induction of expression or subcellular translocation of one or the other isozyme may distinguish their functions. A survey of a limited number of acyl CoA substrates indicates that the two isozymes display similar substrate specificities, although slight differences are suggested by the data. However, extensive analysis of both isozymes with multiple substrates in the same assay system will be required to detect physiologically relevant differences in substrate specificity. LPA and PA are central intermediates in phospholipid biogenesis. Furthermore, they have the capacity to mediate signaling both between and within cells. The importance of these mediators is reflected in the growing body of literature dedicated to unraveling the mechanistic basis for their actions. Until recently, the field has been hampered by a dearth of reagents appropriate for the molecular dissection of the LPA and PA metabolic and signaling pathways in eukaryotes. However, the recent cloning of possible LPA receptors will promote further understanding of LPA signaling. Similarly, the recent appearance of LPAAT homologs in the EST database has prompted a flurry of reports describing their characterization. These clones will afford opportunity for defining the function of LPAAT in eukaryotic phospholipid metabolism.


Subject(s)
Acyltransferases/genetics , DNA, Complementary/genetics , Isoenzymes/genetics , Acyltransferases/metabolism , Animals , COS Cells , Cell Line , Chromosome Mapping , Chromosomes, Human, Pair 6/genetics , Chromosomes, Human, Pair 9/genetics , Cloning, Molecular , Gene Expression , Humans , Isoenzymes/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Subcellular Fractions/enzymology , Tissue Distribution
12.
Proc Natl Acad Sci U S A ; 95(24): 14500-5, 1998 Nov 24.
Article in English | MEDLINE | ID: mdl-9826729

ABSTRACT

The HIV-1 envelope protein gp120 induces apoptosis in hippocampal neurons. Because chemokine receptors act as cellular receptors for HIV-1, we examined rat hippocampal neurons for the presence of functional chemokine receptors. Fura-2-based Ca imaging showed that numerous chemokines, including SDF-1alpha, RANTES, and fractalkine, affect neuronal Ca signaling, suggesting that hippocampal neurons possess a wide variety of chemokine receptors. Chemokines also blocked the frequency of spontaneous glutamatergic excitatory postsynaptic currents recorded from these neurons and reduced voltage-dependent Ca currents in the same neurons. Reverse transcription-PCR demonstrated the expression of CCR1, CCR4, CCR5, CCR9/10, CXCR2, CXCR4, and CX3CR1, as well as the chemokine fractalkine in these neurons. Both fractalkine and macrophage-derived chemokine (MDC) produced a time-dependent activation of extracellular response kinases (ERK)-1/2, whereas no activation of c-JUN NH2-terminal protein kinase (JNK)/stress-activated protein kinase, or p38 was evident. Furthermore, these two chemokines, as well as SDF-1alpha, activated the Ca- and cAMP-dependent transcription factor CREB. Several chemokines were able also to block gp120-induced apoptosis of hippocampal neurons, both in the presence and absence of the glial feeder layer. These data suggest that chemokine receptors may directly mediate gp120 neurotoxicity.


Subject(s)
Chemokines/pharmacology , Gene Expression Regulation , HIV Envelope Protein gp120/toxicity , HIV-1 , Hippocampus/physiology , Neurons/physiology , Neurotoxins/toxicity , Receptors, Chemokine/genetics , Signal Transduction/physiology , Animals , Calcium/metabolism , Cell Death/drug effects , Cells, Cultured , DNA Primers , Embryo, Mammalian , Evoked Potentials/drug effects , Evoked Potentials/physiology , Gene Expression Regulation/drug effects , Hippocampus/cytology , Humans , Mice , Neurons/cytology , Neurons/drug effects , Rats , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Synapses/drug effects , Synapses/physiology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
13.
J Leukoc Biol ; 64(1): 49-54, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9665274

ABSTRACT

High throughput partial sequencing of randomly selected cDNA clones has proven to be a powerful tool for examining the relative abundance of mRNAs and for the identification of novel gene products. Because of the important role played by macrophages in immune and inflammatory responses, we sequenced over 3000 randomly selected cDNA clones from a human macrophage library. These sequences represent a molecular inventory of mRNAs from macrophages and provide a catalog of highly expressed transcripts. Two of the most abundant clones encode recently identified CC chemokines. Macrophage-derived chemokine (MDC) plays a complex role in immunoregulation and is a potent chemoattractant for dendritic cells, T cells, and natural killer cells. The chemokine receptor CCR4 binds MDC with high affinity and also responds by calcium flux and chemotaxis. CCR4 has been shown to be expressed by Th2 type T cells. Recent studies also implicate MDC as a major component of the host defense against human immunodeficiency virus.


Subject(s)
Chemokines/biosynthesis , Chemokines/genetics , DNA, Complementary/analysis , Macrophages/metabolism , RNA, Messenger/metabolism , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , Humans
14.
J Biol Chem ; 273(8): 4289-92, 1998 Feb 20.
Article in English | MEDLINE | ID: mdl-9468473

ABSTRACT

Human immunodeficiency virus, type I (HIV-1) cell-type tropism is dictated by chemokine receptor usage: T-cell line tropic viruses use CXCR4, whereas monocyte tropic viruses primarily use CCR5 as fusion coreceptors. CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES (regulated on activation normal T cell expressed and secreted) inhibit CD4/CCR5-mediated HIV-1 cell fusion. MCP-2 is also a member of the CC chemokine subfamily and has the capacity to interact with at least two receptors including CCR-1 and CCR2B. In an effort to further characterize the binding properties of MCP-2 on leukocytes, we observed that MCP-2, but not MCP-1, effectively competed with MIP-1beta for binding to monocytes, suggesting that MCP-2 may interact with CCR5. As predicted, MCP-2 competitively inhibited MIP-1beta binding to HEK293 cells stably transfected with CCR5 (CCR5/293 cells). MCP-2 also bound to and induced chemotaxis of CCR5/293 cells with a potency comparable with that of MIP-1beta. Confocal microscopy indicates that MCP-2 caused remarkable and dose-dependent internalization of CCR5 in CCR5/293 cells. Furthermore, MCP-2 inhibited the entry/replication of HIV-1ADA in CCR5/293 cells coexpressing CD4. These results indicated that MCP-2 uses CCR5 as one of its functional receptors and is an additional potent natural inhibitor of HIV-1.


Subject(s)
CD4 Antigens/physiology , Cell Fusion/physiology , HIV-1/physiology , Monocyte Chemoattractant Proteins/metabolism , Receptors, CCR5/physiology , Virus Replication/physiology , Cells, Cultured , Chemokine CCL8 , Endocytosis , Humans , Receptors, CCR5/metabolism , Recombinant Proteins/metabolism
15.
J Biol Chem ; 273(3): 1764-8, 1998 Jan 16.
Article in English | MEDLINE | ID: mdl-9430724

ABSTRACT

Macrophage-derived chemokine (MDC) is a recently identified member of the CC chemokine family. MDC is not closely related to other chemokines, sharing most similarity with thymus- and activation-regulated chemokine (TARC), which contains 37% identical amino acids. Both chemokines are highly expressed in the thymus, with little expression seen in other tissues. In addition, the genes for MDC and TARC are encoded by human chromosome 16. To explore this relationship in greater detail, we have more precisely localized the MDC gene to chromosome 16q13, the same position reported for the TARC gene. We have also examined the interaction of MDC with CC chemokine receptor 4 (CCR4), recently shown to be a receptor for TARC. Using a fusion protein of MDC with secreted alkaline phosphatase, we observed high affinity binding of MDC-secreted alkaline phosphatase to CCR4-transfected L1.2 cells (Kd = 0.18 nM). MDC and TARC competed for binding to CCR4, while no binding competition was observed for six other chemokines (MCP-1, MCP-3, MCP-4, RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta). MDC was tested for calcium mobilization in L1.2 cells tranfected with seven different CC chemokine receptors. MDC induced a calcium flux in CCR4-transfected cells, but other receptors did not respond to MDC. TARC, which also induced calcium mobilization in CCR4 transfectants, was unable to desensitize the response to MDC. In contrast, MDC fully desensitized a subsequent response to TARC. Both MDC and TARC functioned as chemoattractants for CCR4 transfectants, confirming that MDC is also a functional ligand for CCR4. Since MDC and TARC are both expressed in the thymus, one role for these chemokines may be to attract CCR4-bearing thymocytes in the process of T cell education and differentiation.


Subject(s)
Chemokines, CC/metabolism , Macrophages/chemistry , Receptors, Chemokine/metabolism , T-Lymphocytes/metabolism , Calcium/metabolism , Cell Line , Chemokine CCL17 , Chemokine CCL22 , Chemotaxis, Leukocyte , Chromosome Mapping , Chromosomes, Human, Pair 16 , Humans , Ligands , Protein Binding , Receptors, CCR4 , Transfection
16.
Science ; 278(5336): 290-4, 1997 Oct 10.
Article in English | MEDLINE | ID: mdl-9323208

ABSTRACT

Unique among known human herpesviruses, Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) encodes chemokine-like proteins (vMIP-I and vMIP-II). vMIP-II was shown to block infection of human immunodeficiency virus-type 1 (HIV-1) on a CD4-positive cell line expressing CCR3 and to a lesser extent on one expressing CCR5, whereas both vMIP-I and vMIP-II partially inhibited HIV infection of peripheral blood mononuclear cells. Like eotaxin, vMIP-II activated and chemoattracted human eosinophils by way of CCR3. vMIP-I and vMIP-II, but not cellular MIP-1alpha or RANTES, were highly angiogenic in the chorioallantoic assay, suggesting a possible pathogenic role in Kaposi's sarcoma.


Subject(s)
Chemokines/physiology , HIV-1/physiology , Herpesvirus 8, Human/genetics , Macrophage Inflammatory Proteins/physiology , Neovascularization, Pathologic/etiology , Receptors, Chemokine , Viral Proteins , Animals , CD4-Positive T-Lymphocytes/virology , Chemokines/genetics , Chemokines/metabolism , Chemokines/pharmacology , Chemotaxis, Leukocyte , Chick Embryo , Eosinophils/physiology , Herpesvirus 8, Human/physiology , Humans , Leukocytes, Mononuclear/virology , Macrophage Inflammatory Proteins/genetics , Macrophage Inflammatory Proteins/metabolism , Macrophage Inflammatory Proteins/pharmacology , Neutrophils/physiology , Receptors, CCR3 , Receptors, Cytokine/agonists , Receptors, Cytokine/metabolism , Receptors, HIV/metabolism , Tumor Cells, Cultured , Virus Replication
17.
J Biol Chem ; 272(32): 20299-305, 1997 Aug 08.
Article in English | MEDLINE | ID: mdl-9242711

ABSTRACT

Lysophosphatidic acid (1-acyl-sn-glycero-3-phosphate (LPA)) is a phospholipid with diverse biological activities. The mediator serves as an intermediate in membrane phospholipid metabolism but is also produced in acute settings by activated platelets. LPA is converted to phosphatidic acid, itself a lipid mediator, by an LPA acyltransferase (LPAAT). A human expressed sequence tag was identified by homology with a coconut LPAAT and used to isolate a full-length human cDNA from a heart muscle library. The predicted amino acid sequence bears 33% identity with a Caenorhabditis elegans LPAAT homologue and 23-28% identity with plant and prokaryotic LPAATs. Recombinant protein produced in COS 7 cells exhibited LPAAT activity with a preference for LPA as the acceptor phosphoglycerol and arachidonyl coenzyme A as the acyl donor. Northern blotting demonstrated that the mRNA is expressed in most human tissues including a panel of brain subregions; expression is highest in liver and pancreas and lowest in placenta. The human LPAAT gene is contained on six exons that map to chromosome 9, region q34.3.


Subject(s)
Acyltransferases/metabolism , Chromosomes, Human, Pair 9 , Amino Acid Sequence , Animals , Arachidonic Acid/metabolism , Base Sequence , Caenorhabditis elegans , Chromosome Banding , Cloning, Molecular , DNA, Complementary/chemistry , Humans , Lysophospholipids/metabolism , Molecular Sequence Data , Sequence Alignment
18.
J Biol Chem ; 272(31): 19236-41, 1997 Aug 01.
Article in English | MEDLINE | ID: mdl-9235916

ABSTRACT

We have identified a novel p110 isoform of phosphatidylinositol 3-kinase from human leukocytes that we have termed p110delta. In addition, we have independently isolated p110delta from a mouse embryo library on the basis of its ability to interact with Ha-RasV12 in the yeast two-hybrid system. This unique isoform contains all of the conserved structural features characteristic of the p110 family. Recombinant p110delta phosphorylates phosphatidylinositol and coimmunoprecipitates with p85. However, in contrast to previously described p110 subunits, p110delta is expressed in a tissue-restricted fashion; it is expressed at high levels in lymphocytes and lymphoid tissues and may therefore play a role in phosphatidylinositol 3-kinase-mediated signaling in the immune system.


Subject(s)
Leukocytes/enzymology , Phosphotransferases (Alcohol Group Acceptor)/chemistry , Amino Acid Sequence , Animals , Binding Sites , Humans , Mice , Molecular Sequence Data , Phosphatidylinositol 3-Kinases , Phosphotransferases (Alcohol Group Acceptor)/genetics , Phosphotransferases (Alcohol Group Acceptor)/physiology
19.
Blood ; 89(9): 3315-22, 1997 May 01.
Article in English | MEDLINE | ID: mdl-9129037

ABSTRACT

Chemokines are a family of related proteins that regulate leukocyte infiltration into inflamed tissue. Some chemokines such as MIP-1 alpha also inhibit hematopoietic progenitor cell proliferation. Recently, three chemokines, MIP-1 alpha, MIP-1 beta, and RANTES, have been found to significantly decrease human immunodeficiency virus production from infected T cells. We report here the cloning and characterization of a novel human chemokine termed Exodus for its chemotactic properties. This novel chemokine is distantly related to other chemokines (28% homology with MIP-1 alpha) and shares several biological activities. Exodus is expressed preferentially in lymphocytes and monocytes, and its expression is markedly upregulated by mediators of inflammation such as tumor necrosis factor or lipopolysaccharide. Purified synthetic Exodus was found to inhibit proliferation of myeloid progenitors in colony formation assays. Exodus also stimulated chemotaxis of peripheral blood mononuclear cells. The sequence homology, expression, and biological activity indicate that Exodus represents a novel divergent beta-chemokine.


Subject(s)
Chemokines, CC , Chemokines/biosynthesis , Hematopoietic Stem Cells/physiology , Islets of Langerhans/metabolism , Macrophage Inflammatory Proteins , Receptors, Chemokine , Amino Acid Sequence , Base Sequence , Blotting, Northern , Bone Marrow Cells , Cell Line , Chemokine CCL20 , Chemokines/chemistry , Chemokines/pharmacology , Chemotaxis/drug effects , Cloning, Molecular , DNA, Complementary , Gene Library , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/drug effects , Humans , Kinetics , Molecular Sequence Data , Organ Specificity , Receptors, CCR6 , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Sequence Homology, Amino Acid , Transcription, Genetic , Tumor Cells, Cultured
20.
J Exp Med ; 185(9): 1595-604, 1997 May 05.
Article in English | MEDLINE | ID: mdl-9151897

ABSTRACT

A cDNA encoding a novel human chemokine was isolated by random sequencing of cDNA clones from human monocyte-derived macrophages. This protein has been termed macrophage-derived chemokine (MDC) because it appears to be synthesized specifically by cells of the macrophage lineage. MDC has the four-cysteine motif and other highly conserved residues characteristic of CC chemokines, but it shares <35% identity with any of the known chemokines. Recombinant MDC was expressed in Chinese hamster ovary cells and purified by heparin-Sepharose chromatography. NH2-terminal sequencing and mass spectrophotometry were used to verify the NH2 terminus and molecular mass of recombinant MDC (8,081 dalton). In microchamber migration assays, monocyte-derived dendritic cells and IL-2-activated natural killer cells migrated to MDC in a dose-dependent manner, with a maximal chemotactic response at 1 ng/ml. Freshly isolated monocytes also migrated toward MDC, but with a peak response at 100 ng/ml MDC. Northern analyses indicated MDC is highly expressed in macrophages and in monocyte-derived dendritic cells, but not in monocytes, natural killer cells, or several cell lines of epithelial, endothelial, or fibroblast origin. High expression was also detected in normal thymus and less expression in lung and spleen. Unlike most other CC chemokines, MDC is encoded on human chromosome 16. MDC is thus a unique member of the CC chemokine family that may play a fundamental role in the function of dendritic cells, natural killer cells, and monocytes.


Subject(s)
Chemokines, CC/genetics , Chemotaxis, Leukocyte , Dendritic Cells/physiology , Killer Cells, Natural/physiology , Macrophage Inflammatory Proteins/genetics , Macrophages/physiology , Monocytes/physiology , Amino Acid Sequence , Chemokine CCL22 , Chemokines, CC/isolation & purification , Chromosomes, Human, Pair 16 , Cloning, Molecular , DNA, Complementary/genetics , Gene Expression , Humans , Molecular Sequence Data , Phylogeny , RNA, Messenger/genetics , Sequence Alignment , Sequence Homology, Nucleic Acid , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...